Paper16161069
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J and 10 others. Head Neck, 2005. Cited by 1,334 papers, by iCite.
Cite this record
ConductScience Library. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Papers, record 16161069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16161069
- Disease
- head and neck squamous cell carcinoma424 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
- PubMed
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Head and Neck Neoplasms | Major topic |
| Randomized Controlled Trials as Topic | Major topic |
| Antineoplastic Agents | |
| Cisplatin | |
| Combined Modality Therapy | |
| Humans | |
| Neoplasm Recurrence, Local | |
| Neoplasm Staging | |
| Prognosis | |
| Risk | |
| Survival Analysis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5U10 CA11488 | NCI NIH HHS | United States | U10CA011488 | PubMed and NIH | NIH RePORTER |
| 5U10 CA11488-33 | NCI NIH HHS | United States | U10CA114883 | PubMed | NIH RePORTER |
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00002555 | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer | Results | ClinicalTrials.gov | |
| NCT00002670 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery | Background | ClinicalTrials.gov | |
| NCT03532737 | Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer | Background | ClinicalTrials.gov | |
| NCT05590650 | A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients | Background | ClinicalTrials.gov | |
| NCT06492460 | 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma | Results | ClinicalTrials.gov |
Cited by575
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,334 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935733 | Beyond binary: a novel anatomical-geographical-biological framework for perineural invasion risk stratification in oral squamous cell carcinoma - a proof-of-concept study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935733 | PubMed |
| 42926249 | Real-world surgical outcomes and prognostic factors in stage III-IVA laryngeal squamous cell carcinoma: a multicenter, retrospective, cohort study in northern Japan. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42926249 | PubMed |
| 42848197 | [Combination of radiotherapy and medicinal anticancer therapy with curative intent]. | Radiologie (Heidelb) | 2026 | https://conductscience.org/library/papers/42848197 | PubMed |
| 42828556 | Boesenbergia rotunda extract-based mucoadhesive mouth gargle for chemoradiation-induced oral mucositis: A prospective randomized controlled study. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42828556 | PubMed |
| 42807568 | The efficacy of concurrent chemoradiotherapy with or without nimotuzumab in high-risk patients with locally advanced head and neck squamous cell carcinoma post-surgery: A real-world study. | Precis Radiat Oncol | 2026 | https://conductscience.org/library/papers/42807568 | PubMed |
| 42802279 | Weight loss despite nutritional support predicts poor outcomes after postoperative chemoradiotherapy for high-risk head and neck cancer. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42802279 | PubMed |
| 42795862 | Radiotherapy in Squamous Cell Carcinoma of the Lip: A Systematic Review of Reported Practices, Clinical Outcomes, and Gaps in Consensus. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795862 | PubMed |
| 42752870 | Immune checkpoint inhibitors in resectable and locoregionally advanced HNSCC: past lessons, present evidence, and future directions. | Oncologist | 2026 | https://conductscience.org/library/papers/42752870 | PubMed |
| 42709195 | Neoadjuvant combined immunotherapy with intratumoral TransCon TLR7/8 Agonist and systemic TransCon IL-2 β/y or pembrolizumab in patients with locally advanced oral cancer-a monocentric experience. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42709195 | PubMed |
| 42681211 | Clinical outcomes of near-infrared photoimmunotherapy according to immune checkpoint inhibitor timing and treatment sequence: a multicenter retrospective study. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42681211 | PubMed |
| 42658511 | Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016. | JAMA Otolaryngol Head Neck Surg | 2026 | https://conductscience.org/library/papers/42658511 | PubMed |
| 42618776 | Influence of resection status on overall survival in p16-positive oropharyngeal carcinoma - a retrospective analysis of cancer registry data. | Eur Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42618776 | PubMed |
| 42598158 | Variable-interval temporal feathering to optimize organs-at-risk repair for head and neck adaptive radiotherapy. | Phys Imaging Radiat Oncol | 2026 | https://conductscience.org/library/papers/42598158 | PubMed |
| 42361282 | Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer. | J Clin Oncol | 2026 | https://conductscience.org/library/papers/42361282 | PubMed |
| 42303822 | Event-free survival and recurrence patterns after curative resection for locally advanced head and neck squamous cell carcinoma: single-institution real-world outcomes prior to the introduction of perioperative immunotherapy. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42303822 | PubMed |
| 42279427 | Basic and Clinical Evidence for Perioperative Immunotherapy in Resectable HNSCC. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279427 | PubMed |
| 42237748 | YAP-activated lymph node fibroblasts contribute to extracellular matrix remodeling associated with extranodal extension of oral squamous cell carcinoma. | J Pathol Clin Res | 2026 | https://conductscience.org/library/papers/42237748 | PubMed |
| 42221217 | Development of a Prognostic Nomogram Model and Establishment of a Risk Stratification System Based on the Naples Prognostic Score for Patients with Oropharyngeal Squamous Cell Carcinoma Who Have Undergone Radical Surgery. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42221217 | PubMed |
| 42213481 | Cancer vaccines: comprehensive review. | BJS Open | 2026 | https://conductscience.org/library/papers/42213481 | PubMed |
| 42179829 | Commencement of Hypofractionated Adjuvant Radiation Therapy in Intermediate-Risk Oral Cavity Cancer: A Phase 1 Study Protocol (CHARIOT-1). | Adv Radiat Oncol | 2026 | https://conductscience.org/library/papers/42179829 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| CISPLATIN | CHEMBL11359 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL11359 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16161069
GET https://conductscience.org/api/papers/v1/16161069/cited_by?page=2